Paul Zdinak

  • 4th Year GS

Why did you choose the University of Pittsburgh?

I chose Pitt Immunology for the quality of the research faculty and the practice of collaboration rather than the buzzword. It is place were meaningful and impactful research can be done without a sink or swim atmosphere.

Education & Training

  • B.S. in Biology: Concentration in Cell and Molecular Biology, George Washington University, 2018
  • M.S. in Biology: Concentration in Microbiology, Ohio University, 2020

Research Interests

Autoimmunity, T cell antigen discovery, T cell engineering


Rui André Saraiva Raposo, Miguel de Mulder Rougvie, Dominic Paquin-Proulx, Phillip M Brailey, Vinicius D Cabido, Paul M Zdinak, Allison S Thomas, Szu-Han Huang, Greta A Beckerle, Richard B Jones, Douglas F Nixon. (2017). IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. Jan 12;2(1):e85811. doi: 10.1172/jci.insight.85811.